Morepen Laboratories posts Q2 FY24 consolidated PAT at Rs. 21.25 Cr
News

Morepen Laboratories posts Q2 FY24 consolidated PAT at Rs. 21.25 Cr

Morepen Laboratories has reported total income of Rs. 425 crores during the quarter ended September 30, 2023

  • By IPP Bureau | November 03, 2023

Morepen Laboratories Limited has reported Consolidated financial results for the period ended September 30, 2023.

Morepen Laboratories has posted net profit of Rs. 21.25 crores for the period ended September 30, 2023 as against net profit of Rs. 14.63 crores for the period ended June 30, 2023. The company posted net profit of Rs.15.81 crores for the period ended September 30, 2022.

Morepen Laboratories has reported total income of Rs. 425 crores during the period ended September 30, 2023 as compared to Rs. 403.45 crores during the period ended June 30, 2023. The company reported total income of Rs.403.85 crores during the period ended September 30, 2022.

For the Half Year ended September 30, 2023, Morepen Laboratories has reported total income of Rs.828.46 crores as compared to Rs.707.16 crores during the 6 months period ended September 30, 2022.

The company has posted net profit of Rs.35.88 crores for the 6 months period ended September 30, 2023 as against net profit of Rs.21.44 crores for the 6 months period ended September 30, 2022.

Upcoming E-conference

Other Related stories

Startup

Digitization